Jeff Yass’s Achieve Life Sciences QUIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$284K Buy
35,095
+4,723
+16% +$33.8K ﹤0.01% 11090
2026
Q2
$198K Sell
30,372
-353,311
-92% -$1.68M ﹤0.01% 11961
2026
Q1
$1.13M Sell
383,683
-112,667
-23% -$500K ﹤0.01% 7566
2025
Q4
$2.47M Buy
496,350
+129,987
+35% +$567K ﹤0.01% 5218
2025
Q3
$1.15M Buy
366,363
+293,648
+404% +$806K ﹤0.01% 7011
2025
Q2
$164K Sell
72,715
-7,960
-10% -$22.7K ﹤0.01% 11408
2025
Q1
$215K Buy
80,675
+58,141
+258% +$181K ﹤0.01% 10794
2024
Q4
$79.3K Buy
+22,534
New +$102K ﹤0.01% 11471
2024
Q2
– Sell
-44,653
Closed -$215K – 11919
2024
Q1
$203K Buy
+44,653
New +$198K ﹤0.01% 10570
2023
Q4
– Sell
-11,290
Closed -$49.2K – 12249
2023
Q3
$48.5K Buy
+11,290
New +$56.9K ﹤0.01% 11322
2023
Q1
– Sell
-20,755
Closed -$98.6K – 12455
2022
Q4
$51.3K Sell
20,755
-8,522
-29% -$21.9K ﹤0.01% 11388
2022
Q3
$97K Sell
29,277
-13,022
-31% -$62.1K ﹤0.01% 11730
2022
Q2
$206K Sell
42,299
-38,145
-47% -$259K ﹤0.01% 10553
2022
Q1
$609K Sell
80,444
-19,858
-20% -$148K ﹤0.01% 8446
2021
Q4
$780K Buy
100,302
+74,965
+296% +$589K ﹤0.01% 7945
2021
Q3
$215K Buy
+25,337
New +$199K ﹤0.01% 11327
2021
Q1
– Sell
-10,510
Closed -$85K – 12171
2020
Q4
$85K Buy
+10,510
New +$89K ﹤0.01% 10573
2020
Q2
– Sell
-1,054
Closed -$7K – 10029
2020
Q1
$7K Buy
+1,054
New +$10.2K ﹤0.01% 10068
2018
Q4
– Sell
-1,482
Closed -$93K – 8829
2018
Q3
$93K Buy
+1,482
New +$93.7K ﹤0.01% 8630
2018
Q2
– Sell
-133
Closed -$34K – 9507
2018
Q1
$34K Buy
133
+76
+133% +$21.7K ﹤0.01% 9053
2017
Q4
$15K Buy
+57
New +$18.2K ﹤0.01% 9095
2017
Q3
– Sell
-35
Closed -$28K – 8727
2017
Q2
$28K Buy
+35
New +$28.4K ﹤0.01% 8982
2017
Q1
– Sell
-38
Closed -$42K – 8818
2016
Q4
$42K Buy
38
+7
+23% +$6.92K ﹤0.01% 9327
2016
Q3
$35K Buy
+31
New +$49.4K ﹤0.01% 8196
2016
Q1
– Sell
-10
Closed -$25K – 8925
2015
Q4
$25K Sell
10
-15
-60% -$63.4K ﹤0.01% 9198
2015
Q3
$123K Buy
25
+19
+317% +$114K ﹤0.01% 9032
2015
Q2
$32K Buy
+6
New +$29.8K ﹤0.01% 9939
2015
Q1
– Sell
-20
Closed -$98.2K – 9341
2014
Q4
$99K Sell
20
-14
-41% -$68.4K ﹤0.01% 9191
2014
Q3
$198K Sell
34
-41
-55% -$285K ﹤0.01% 8691
2014
Q2
$618K Buy
75
+32
+74% +$393K ﹤0.01% 7069
2014
Q1
$1.12M Buy
43
+37
+617% +$909K ﹤0.01% 5314
2013
Q4
$114K Buy
+6
New +$105K ﹤0.01% 8579

Other funds holding QUIT

Jeff Yass's QUIT Position: Q3 2026 in Review

Jeff Yass increased its Achieve Life Sciences (QUIT) stake by 16% in Q3 2026, buying an estimated $33.8K and bringing the position to 35,095 shares worth $284K. The position accounts for ﹤0.01% of the portfolio, ranked #11090.

Jeff Yass first reported a position in QUIT in Q4 2013 and has held it in 32 quarters since. The position peaked at $2.47M in Q4 2025. 131 funds tracked by Wall St. Rank hold QUIT as of Q3 2026.

  • Jeff Yass held 35,095 shares of Achieve Life Sciences worth $284K as of Q3 2026.
  • Jeff Yass bought 4,723 Achieve Life Sciences shares in Q3 2026, an estimated $33.8K.
  • Achieve Life Sciences made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #11090 holding.
  • Jeff Yass first reported a position in Achieve Life Sciences in Q4 2013 and has held it in 32 quarters since.
  • Jeff Yass's Achieve Life Sciences position peaked at $2.47M in Q4 2025.
  • 131 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.